Edwards CM, Cusi K. Prediabetes: a worldwide epidemic.
Endocrinol Metab Clin N Am 2016; 45: 751-764
http://dx.doi.org/10.1016/j.ecl.2016.06.007
Ferrannini E. Definition of intervention points in prediabetes.
Lancet Diabetes Endocrinol 2014; 2:667-75. doi:10.1016/S2213-
8587(13)70175-X.
GrundySM,,2012,Pre-diabetes, metabolic syndrome and cardiovascular risk,J Am Coll Cardiol,59,635,43
AmericanDiabetes,Association,,2017,Prevention or delay of type 2 diabetes,Diabetes Care,40,S008,S47
Garber AJ, Abrahamson MJ, Barzilay JI, Lawrence B, Zachary T.
Bloomgarden et.al. (2016) Consensus statement by the American
Association of Clinical Endocrinologists and American College of
Endocrinology on the comprehensive type 2 diabetes management algorithm - 2016 executive summary. Endocrine
Practice: 2016; 22: 84-113.
Kanat M, DeFronzo R, Abdul-Ghani MA. Treatment of prediabetes.
World J Diabetes 2015; 6: 1207-1222
Kerrison G, Gillis RB, Jiwani SI, Alzahrani Q, Kok S, Harding SE et.al.
The effectiveness of lifestyle adaptation for the prevention of
prediabetes in adults: a systematic review. Journal of Diabetes
Research. 2017, DOI: 10.1155/2017/8493145
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD,
Vijay V; Indian Diabetes Prevention Programme (IDPP). The Indian
Diabetes Prevention Programme shows that lifestyle modification
and metformin prevent type 2 diabetes in Asian Indian subjects
with impaired glucose tolerance (IDPP-1). Diabetologia 2006;
48:289-97. Epub 2006 Jan 4.
Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL,
Jeffries SL, et.al. Diabetes Prevention Program Research Group.
Metformin for diabetes prevention: insights gained from the
Diabetes Prevention Program/ Diabetes Prevention Program
Outcomes Study. Diabetologia. 2017; doi: 10.1007/s00125-017-
4361-9.
GarveyWT,MechanickJI,BrettEM,GarberAJ,HurleyDL,JastreboffAM,,2016,American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity,Endocrine Practice: (Supplement 3),22,1,203
Portero McLellan KC, Wyne K, Villagomez ET, Hsueh WA.
Therapeutic interventions to reduce the risk of progression from
prediabetes to type 2 diabetes mellitus. Ther Clin Risk Manag
2014; 10: 173-88. doi:10.2147/TCRM.S39564.